Janux Therapeutics, Inc. ($JANX)
Filing Information
| Accession Number | 0001864159-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 3, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
1,879
Total Value
$25,798.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Common Stock | โ | Jan 2, 2026 | Sale | 1,879 | $13.73 | $25,798.67 | 83,095 | Direct | โ | View Details |